Related Experiment Video

Updated: Apr 28, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

10.6K

Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression

Jamie J L Williams1, Kirsten M A Munro2, Timothy M Palmer3

  • 1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK. Jamie.Williams@glasgow.ac.uk.

Cells
|June 3, 2014
PubMed

Insights

Suppressor of cytokine signaling 3 (SOCS3) inhibits the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. This review explores SOCS3's role in diseases and its therapeutic potential for conditions like vascular re-stenosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is crucial in cellular signaling.
  • Unregulated JAK-STAT pathway activation drives various diseases, making its components therapeutic targets.
  • Suppressor of cytokine signaling 3 (SOCS3) is an inducible inhibitor of this pathway.

Purpose of the Study:

  • To review the role of SOCS3 in inhibiting JAK-STAT signaling.
  • To discuss SOCS3's involvement in diseases, including myeloproliferative disorders.
  • To explore therapeutic strategies based on SOCS3 for conditions like vascular re-stenosis.

Main Methods:

  • Literature review of JAK-STAT signaling and SOCS3 function.
  • Analysis of SOCS3's role in disease pathogenesis.
  • Evaluation of potential therapeutic applications of SOCS3 modulation.

Main Results:

  • SOCS3 acts as a key inhibitor of the JAK-STAT pathway.
  • SOCS3 functions within a multi-subunit E3 ubiquitin ligase complex.
  • Evidence suggests SOCS3 potentiation can attenuate disease progression in vascular re-stenosis.

Conclusions:

  • SOCS3 is a critical regulator of JAK-STAT signaling with implications in various diseases.
  • Targeting SOCS3 offers potential therapeutic strategies for inflammatory and proliferative conditions.
  • Localized enhancement of SOCS3 expression may be beneficial for treating vascular re-stenosis.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.6K
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity09:45

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

Published on: January 29, 2018

8.8K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
6.6K